Abstract
The aim of this report is to describe the frequency, clinical, and morphologic characteristics of fibrolamellar hepatocellular carcinoma in Mexican patients. Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare variant of hepatocellular carcinoma. Although this tumor appears to be predominant among the Caucasian population of the U.S, FLHCC has been described in many other countries. The frequency and characteristics of FLHCC in Latin American population is almost unknown. The clinico-pathologic characteristics of seven (5.8%) Mexican patients with FLHCC, obtained among 121 hepatocellular carcinomas are described. The frequency of these tumors was compared with the frequency reported in other geographic areas in the international literature between 1980 and 1999. There were four women and three men. Two patients had taken oral contraceptives for six months and a year prior to diagnosis; another patient had positive serology for the hepatitis B virus. Common symptoms included a palpable mass, abdominal pain and weight loss; two patients presented jaundice. In two patients the tumor had been removed eight and three years previously, and they were readmitted when FLHCC recurred. In three patients the diagnosis was suspected in radiological studies (computed tomography and/or magnetic resonance). Laboratory tests were non-specific. In four patients, resection of the tumor was performed, and in the remaining three the neoplasm was diagnosed by percutaneous hepatic biopsy. Two patients had died of disease at the time of the study, and another was alive with recurrent disease. Conclusions: fibrolamellar hepatocarcinoma is an uncommon, but not an exceptional neoplasm in our population and represents 5.8% of all hepatocarcinomas reviewed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Saab S, Yao F: Fibrolamellar hepatocellular carcinoma. Case reports and a review of the literature. Dig Dis Sci 41:1981–1985, 1996.
Ruffin MT: Fibrolamellar hepatoma. Am J Gastroenterol 85: 577–581, 1990.
Téilez-Zenteno JF, Hernández-Ronquillo L, Tapia-Rangel B, et al. Hepatocarcinoma variedad fibrolamelar en unajoven de 17 anos de edad. Gac Med Mex 135: 83–87, 1999.
Chedid A, Ryan LM, Dayal Y, et al: Morphology and other prognostic factors of hepatocellular carcinoma. Arch Pathol Lab Med 123:524–8, 1999.
Wood WJ, Raelings M, Evans H, et al: Hepatocellular carcinoma: importance of histologic classification as a prognostic factor. Am J Surg 155: 663–666, 1988.
Yoshida K, Amemiya A, Kobayashi S, et al. Fibrolamellar carcinoma of the liver in the Orient. J Surg Oncol 39: 187–189, 1988.
Kearney D, Donlon JB, Mendelson RM: A case of fibrolamellar hepatocelullar carcinoma. Australas Radiol 35: 88–91, 1991.
Barsu M: Fibrolamellar hepatocarcinoma: case report and review of the literature. Rom J Morphol Embryol 37:161–166, 1991.
Tanaka J, Baba N, Arü S, et al: Typical fibrolamellar hepatocellular carcinoma in Japanese patients: report of two cases. Surg Today 24: 459–463, 1994.
Kaczynski J, Gustavsson B, Hansson G, et al. Fibrolamellar hepatic carcinoma in an area with a iow incidence of primary liver cancer: a retrospective study. Eur J Surg 162: 367–371, 1996.
Lemmer ER, Krige JE, Hall PM, et al: Surgical resection for hepatocelullar carcinoma in Cape Towna clinical and histopathoiogical study. S Afr Med J 88: 1575–1580, 1998.
Yamaguchi R, Tajika T, Kanda H, et al: Fibrolamellar carcinoma of the liver. Hepatogastroenterology 46: 1706–1709, 1999.
Ichikawa T, Federle MP, Grazioü L, et al. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 213: 352–361, 1999.
Kufkarni MS, Mathur SK, Nagral SS, et al: Fibrolamellar hepatocellular carcinoma. Indian J Gastroenterol 13: 148–149, 1994.
Arslan I, Oner K, Kilicturgay S. et al: Fibrolamellar hepatocellular carcinoma. “It is not a ordinary case for Mediterranean countries”. HPB Surg 9: 51–53, 1995.
Ashraf SJ, Arya SC, el-Sayed M, et al. A profile of primary hepatocellular carcinoma patients in the Gizan Area of Saudi Arabia. Cancer 58:2163–2168, 1986.
Lapis K, Schaff Z, Kopper L, et al: Fibrolamellar liver carcinoma. Zentralbl Allg Pathol 136: 135–149, 1990.
Van Leeuwen DJ, Bos RJ, Vidacovic-Vucic MM: Hepatocellular carcinoma in the Amsterdam area. A retrospective analysis in 61 patients. Scand J Gastroenterol Suppl 188:108–17, 1991.
Yuan CY, Yuan CC, Shiou GF, et al: Fibrolamellar variant of hepatocellular carcinoma-report of a Chinese patient. Hepatogastroenterology 42:182–184, 1995.
Haratake J, Hone A, Lee SD, et al: Fibrolamellar carcinoma of the fiver in a middle-aged Korean man. J UOEH 12:349–54, 1990.
Andreola S, Audisio RA, Lombardi L: A light microscopic and ultrastructural study of two cases of fibrolamellar hepatocellular carcinoma. Tumori 72: 609–6016. 1986.
Vlalondra AB, Picornell MF, Pons JT, et al: European cases of fibrolamellar hepatocellular carcinoma. (Letter). Ann Intern Med 110:324, 1989.
Caballero T, Aneiros J, López-Caballero J, et al: Fibrolamellar hepatocellular carcinoma: an immunohistochemical and ultrastructuraf study. Histopathology 9:445–456, 1985.
Klompmaker IJ, Haagsma EB, Verwer R, et al: Fibrolamellar hepatoma in Europe. (Letter). Am J Gastroenterol 86:790–791, 1991.
Guix Pericás M, Sancho Poch F, Pladellorens Roca M, et al: Hepatocarcinoma fibrolamelar: presentación de dos casos. Gastroenterol Hepatol 6:475–479, 1983.
Vecchio FM, Fabiano A, Ghirlanda G, et al. Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic change. Am J Clin Pathol 81:521–526, 1984.
Soreide O, Czerniak A, Bradpiece H, et al. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature: Am J Surg 151:518–523, 1986.
Bore VB, Chasle J, Raffy P, et al: Le carcinoma fibrofamillaire du fori, a propos dune observation. Arch Anat Cytol Pathol 30:109–112, 1982.
Ratia-Gimenez T, Herrera CJ, Pereíra PF, et al: Liver transplant in fibrolamellar hepatocarcinoma. A case report and review of the literature. Rev Esp Enferm Apar Dig 75:273–276, 1989.
Kahle M, Heilman KL, Filler RD: Das fibrolamellare leberzellkarzinom Ein failbericht. Z Gastroenterol 27:341–2, 1989.
Zheng ZZ: Fibrolamellar carcinoma of the liver: Clinicopathologic analysis of six cases. Ching Hua Ko Tsa Chih 26:617–619, 1988.
Sifva H, León G, Naquira N: Fibrolamellar hepatocellular carcinoma. Report of four cases. Rev Med Chile 116:153–156, 1988.
Berman MA, Burnham JA, Sheahan DG: Fibrolamellar carcinoma of the liver. An immunohistochemical study of nineteen cases and a review of the literature. Human Pathol 19:784–94, 1988.
Dunk AA, Spüiadis H, Sherlock S, et al: Hepatocellular carcinoma: cfinicaf, aetio4ogical and pathological features in British patients. Int J Cancer 41:17–23, 1988.
Kahno H, Nagasue N, Taniura H, et al. Fibrolamellar carcinoma of the liver-a case report from Japan and a review of the literature. HPB Surg 1:77–80, 1988.
Eckstein RP, Bambach CP;Stiel D, et al: Fibrolamellar carcinoma as a cause of bile duct obstruction. Pathology 20:326–31, 1988.
Azais-Nobünski B;Dahan D, Tubiana JM: Fibrolamellar carcinoma of the liver. Apropos of 2 cases. Review of the literature. Ann Radiol (Paris) 30:395–399, 1897.
Grases PJ, Ruiz MC, Aparcero M, et al. Fibrolamellar carcinoma of the liver apropos of a case with successful resection. GEN 40:75–82, 1986.
Pérez Blanco FJ, Urbano Jiménez FJ, Caballero Morates T, et al: A new case of fibrofamellar hepatocarcinoma. Rev Esp Enfer Apar Dig 67:551–555, 1985.
Denis J, Grippon P, Legendre C, et al: Fibrolamellar carcinoma of the liver: hepatocellular carcinoma with favorable prognosis. Gastroenterol Clin Biol 8:920–924, 1984.
Schechter D, Shefer R, Yosípov J, et al. Fibrolamellar carcinoma of the liver. Nareua 113:160–1, 1987.
Eyskens E, Van der Stighelen Y, Bourgeois N: Icterogenic hepatocellular carcinoma and polygonal cell carcinoma with fibrous stroma (fibrolamellar hepatocarcinoma). Acta Chir Belg 87:19–25, 1987.
Berman MM, Libbey NP, Foster JH: Hepatocelullar carcinoma polygonal cell type with fibrous stroma — an atypical variant with a favorable prognosis. Cancer 46:1448–1455, 1980
Borges AM, Swaroop VS, Desai PB: Response to Dr. Ruffin. (Letter). Am J Gastroenterol 86:789–790, 1991.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arista-Nasr, J., Gutierrez-Villalobos, L., Nuncio, J. et al. Fibrolamellar hepatocellular carcinoma in Mexican patients. Pathol. Oncol. Res. 8, 133–137 (2002). https://doi.org/10.1007/BF03033723
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03033723